» Articles » PMID: 19723455

Assessment of Myocardial Ischemia and Viability Using Cardiac Magnetic Resonance

Overview
Publisher Current Science
Date 2009 Sep 3
PMID 19723455
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

In the past decade, cardiac magnetic resonance (CMR) has evolved dramatically. Its clinical applications are now a major tool in the diagnosis and prognostic assessment of patients with ischemic heart disease. CMR can be used for detection and quantification of ischemia and for viability assessment using different techniques that are now well validated. Scar can be easily detected using contrast enhancement (late gadolinium enhancement). Ischemia detection is usually achieved with stress CMR techniques, whereas prediction for the recovery of function (detection of dysfunctional but viable myocardial segments) can be deduced from scar and stress imaging. Although determination of which approach is better may depend on the population group, the major advantage of CMR is the ability to integrate different information about anatomy, wall motion, myocardial perfusion, and tissue characterization in a single comprehensive examination.

Citing Articles

Cardiovascular Magnetic Resonance Imaging in Myocardial Disease.

Popa O, Amzulescu M, Bugeac C, Tomescu L, Slavu I, Gheorghita V Cureus. 2024; 16(4):e58688.

PMID: 38774162 PMC: 11107957. DOI: 10.7759/cureus.58688.


Low-dose dobutamine cardiovascular magnetic resonance segmental strain study of early phase of intramyocardial hemorrhage rats.

Xia R, He B, Zhu T, Zhang Y, Chen Y, Wang L BMC Med Imaging. 2021; 21(1):173.

PMID: 34800982 PMC: 8605595. DOI: 10.1186/s12880-021-00709-x.


Quantification of Myocardial Deformation Applying CMR-Feature-Tracking-All About the Left Ventricle?.

Lange T, Schuster A Curr Heart Fail Rep. 2021; 18(4):225-239.

PMID: 33931818 PMC: 8342400. DOI: 10.1007/s11897-021-00515-0.


CMR for myocardial characterization in ischemic heart disease: state-of-the-art and future developments.

Emrich T, Halfmann M, Schoepf U, Kreitner K Eur Radiol Exp. 2021; 5(1):14.

PMID: 33763757 PMC: 7990980. DOI: 10.1186/s41747-021-00208-2.


Myocardial Viability on Cardiac Magnetic Resonance.

Souto A, Souto R, Teixeira I, Nacif M Arq Bras Cardiol. 2017; 108(5):458-469.

PMID: 28591322 PMC: 5444893. DOI: 10.5935/abc.20170056.


References
1.
Rerkpattanapipat P, Little W, Clark H, Hamilton C, Link K, Hundley W . Effect of the transmural extent of myocardial scar on left ventricular systolic wall thickening during intravenous dobutamine administration. Am J Cardiol. 2005; 95(4):495-8. DOI: 10.1016/j.amjcard.2004.10.019. View

2.
Doesch C, Seeger A, Doering J, Herdeg C, Burgstahler C, Claussen C . Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. JACC Cardiovasc Imaging. 2009; 2(4):424-33. DOI: 10.1016/j.jcmg.2008.11.017. View

3.
Yan A, Shayne A, Brown K, Gupta S, Chan C, Luu T . Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation. 2006; 114(1):32-9. DOI: 10.1161/CIRCULATIONAHA.106.613414. View

4.
Poon M, Carr J, Gerstad N, Gillam L, Hodgson J, Kim R . ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee.... J Am Coll Cardiol. 2006; 48(7):1475-97. DOI: 10.1016/j.jacc.2006.07.003. View

5.
Geskin G, Kramer C, Rogers W, Theobald T, Pakstis D, Hu Y . Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation. 1998; 98(3):217-23. DOI: 10.1161/01.cir.98.3.217. View